Why Choose Us - Ethica Meds

the World’s First Ethical Drug Company

Imagine a world where medicine starts with you.

At EthicaMeds, we’re pioneering a new era in healthcare — one where drugs aren’t prescribed based on hope or habit, but on your unique genetics. We believe that no one should suffer unnecessary side effects or waste precious time on drugs that have no chance of working.

Precision Before Prescription™

We’ve developed the world’s first genetic test that screens all 5,886 HER2+ TK mutations to determine whether the most commonly prescribed HER2 drugs (and our biosimilar) will actually bind to your HER2 gene — or not.

Why Choose Us?

Unmatched Testing

We’re the first to test every known and newly discovered mutation in HER2+ cancers — not just the top 10.

Patient-First Promise

We pay for the genetic test. Even if our drug isn’t right for you, we’ll tell you. That’s ethics.

Data-Driven Confidence

We’ve tested over 20,000 biosimilar variants in the lab and selected the best-performing one — before clinical trials.

Rapid Drug Development

Thanks to new UK biosimilar regulations, we can bring safe, effective drugs to market in under 3 years, for under $10 million.

Trust through Transparency

When our biosimilar is one of the few drugs that might work for you, you'll know we earned that place.

The Science Behind Our Breakthrough

We test how every mutation interacts with each HER2 drug (including ours), looking for true physiological response, not just molecular binding.
We’ve identified 112 new HER2+ mutations and determined their effect on drug function — insights no one else offers.
Our lead drug candidate was selected only after proving in preclinical tests that it performs as well or better than the original biologic.

Let’s Talk

Whether you’re a physician, patient, investor, or partner — if you’re ready to change the future of medicine, we want to hear from you.

What Doctors and Patients Are Saying

“For the first time, I’m confident I’m not wasting time on a treatment that can’t work.”

— HER2+ Breast Cancer Patient, Age 43

“This level of precision and honesty is unheard of in the pharmaceutical world. This is how medicine should work.”

— Oncologist, London

How to Chang“They put my patient’s outcome ahead of selling their own drug. That’s revolutionary.”e my Subscription Plan using PayPal

— Clinical Researcher, Boston

FAQ

Why aren't other drug companies doing this?

Most companies focus on profit and speed. We focus on saving lives and building long-term trust.

Is this test available now?

We’re currently rolling out our HER2+ test for select clinics and trials. Full patient access is expected soon.

What does it cost?

The genetic test is fully covered by us — no charge to the patient.

Will my doctor understand how to use the test results?

Absolutely. We provide a clear report showing which HER2 drugs are likely to work or not, with supporting data.